HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More

Lihua Chen,1,2,* Binhua Dong,2,3,* Hangjing Gao,2,3 Huifeng Xue,4 Diling Pan,5 Pengming Sun1– 3 1Department of Gynecology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 2Fujian Provincial Key...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen L, Dong B, Gao H, Xue H, Pan D, Sun P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	cervical intraepithelial neoplasia human papillomavirus type 16 pou5f1b hpv integration hpv-e2/e6 Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/5bfb4c49d82d4e2696e69cc742745c8b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5bfb4c49d82d4e2696e69cc742745c8b
record_format	dspace
spelling	oai:doaj.org-article:5bfb4c49d82d4e2696e69cc742745c8b2021-12-02T11:38:23ZHPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More1178-7031https://doaj.org/article/5bfb4c49d82d4e2696e69cc742745c8b2020-10-01T00:00:00Zhttps://www.dovepress.com/hpv-16-e2e6-and-pou5f1b-as-biomarkers-to-determine-cervical-high-grade-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Lihua Chen,1,2,* Binhua Dong,2,3,* Hangjing Gao,2,3 Huifeng Xue,4 Diling Pan,5 Pengming Sun1– 3 1Department of Gynecology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 2Fujian Provincial Key Laboratory of Women and Children Major Disease, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 3Laboratory of Gynecologic Oncology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 4Medical Center of Cervical Disease and Colposcopy, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 5Department of Pathology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Pengming SunFujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, 18 Daoshan Road, Fuzhou 350001, Fujian, People’s Republic of ChinaTel +86-591-87558732 (Lab Office)Fax +86-591-87551247Email sunfemy@hotmail.comPurpose: Human papillomavirus-16 (HPV-16) is the most carcinogenic HPV genotype. This study aimed to evaluate the clinical value of POU5F1B and HPV-16-E2/E6 by cervical cytology specimens to predict the cervical intraepithelial neoplasia two grade and more (CIN2+).Methods: Finally, 248 patients with HPV-16 single infection were enrolled. Using cytology specimen by real-time quantitative PCR (qPCR), POU5F1B mRNA and HPV-16-E2/E6 were detected. The relationship of POU5F1B, HPV-16-E2/E6 and CIN2+ were analyzed, and the optimal cut-off values of POU5F1B and HPV-16-E2/E6 to predict CIN2+ were calculated.Results: The mean HPV-16-E2/E6 decreased signiﬁcantly with cervical lesions development, especially compared with CIN2+ (p< 0.05). And the POU5F1B demonstrated higher expression in CIN2+ than that of normal cervical tissue and CIN1 (p< 0.05). What is more, POU5F1B was negatively correlated with HPV-16-E2/E6. It demonstrated that the area under the receiver operating characteristic curve (AUC) for POU5F1B (0.9058) was higher than that for HPV-16-E2/E6 (0.8983), and the sensitivity and specificity of POU5F1B in the diagnosis of CIN2+ were higher than HPV-E2/E6. Furthermore, it demonstrated that the POU5F1B had the highest odds ratio (OR= 16.84; 95% CI (8.00– 35.46)) for the detection of CIN 2+.Conclusion: HPV-16-E2/E6≤ 0.6471 or POU5F1B≥ 1.0310 in cervical exfoliated cells can be used as a reliable predictor of CIN2+. POU5F1B can be used as a new auxiliary biomarker to determine the HPV infection status and a reliable predictor of CIN2+. The expression of POU5F1B≥ 1.0310 had the highest OR for the detection of CIN2+.Keywords: cervical intraepithelial neoplasia, human papillomavirus type 16, POU5F1B, HPV integration, HPV-E2/E6Chen LDong BGao HXue HPan DSun PDove Medical Pressarticlecervical intraepithelial neoplasiahuman papillomavirus type 16pou5f1bhpv integrationhpv-e2/e6PathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 13, Pp 813-821 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	cervical intraepithelial neoplasia human papillomavirus type 16 pou5f1b hpv integration hpv-e2/e6 Pathology RB1-214 Therapeutics. Pharmacology RM1-950
spellingShingle	cervical intraepithelial neoplasia human papillomavirus type 16 pou5f1b hpv integration hpv-e2/e6 Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Chen L Dong B Gao H Xue H Pan D Sun P HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
description	Lihua Chen,1,2,* Binhua Dong,2,3,* Hangjing Gao,2,3 Huifeng Xue,4 Diling Pan,5 Pengming Sun1– 3 1Department of Gynecology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 2Fujian Provincial Key Laboratory of Women and Children Major Disease, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 3Laboratory of Gynecologic Oncology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 4Medical Center of Cervical Disease and Colposcopy, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China; 5Department of Pathology, Fujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Pengming SunFujian Provincial Maternity and Child Hospital, Affiliated Hospital of Fujian Medical University, 18 Daoshan Road, Fuzhou 350001, Fujian, People’s Republic of ChinaTel +86-591-87558732 (Lab Office)Fax +86-591-87551247Email sunfemy@hotmail.comPurpose: Human papillomavirus-16 (HPV-16) is the most carcinogenic HPV genotype. This study aimed to evaluate the clinical value of POU5F1B and HPV-16-E2/E6 by cervical cytology specimens to predict the cervical intraepithelial neoplasia two grade and more (CIN2+).Methods: Finally, 248 patients with HPV-16 single infection were enrolled. Using cytology specimen by real-time quantitative PCR (qPCR), POU5F1B mRNA and HPV-16-E2/E6 were detected. The relationship of POU5F1B, HPV-16-E2/E6 and CIN2+ were analyzed, and the optimal cut-off values of POU5F1B and HPV-16-E2/E6 to predict CIN2+ were calculated.Results: The mean HPV-16-E2/E6 decreased signiﬁcantly with cervical lesions development, especially compared with CIN2+ (p< 0.05). And the POU5F1B demonstrated higher expression in CIN2+ than that of normal cervical tissue and CIN1 (p< 0.05). What is more, POU5F1B was negatively correlated with HPV-16-E2/E6. It demonstrated that the area under the receiver operating characteristic curve (AUC) for POU5F1B (0.9058) was higher than that for HPV-16-E2/E6 (0.8983), and the sensitivity and specificity of POU5F1B in the diagnosis of CIN2+ were higher than HPV-E2/E6. Furthermore, it demonstrated that the POU5F1B had the highest odds ratio (OR= 16.84; 95% CI (8.00– 35.46)) for the detection of CIN 2+.Conclusion: HPV-16-E2/E6≤ 0.6471 or POU5F1B≥ 1.0310 in cervical exfoliated cells can be used as a reliable predictor of CIN2+. POU5F1B can be used as a new auxiliary biomarker to determine the HPV infection status and a reliable predictor of CIN2+. The expression of POU5F1B≥ 1.0310 had the highest OR for the detection of CIN2+.Keywords: cervical intraepithelial neoplasia, human papillomavirus type 16, POU5F1B, HPV integration, HPV-E2/E6
format	article
author	Chen L Dong B Gao H Xue H Pan D Sun P
author_facet	Chen L Dong B Gao H Xue H Pan D Sun P
author_sort	Chen L
title	HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
title_short	HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
title_full	HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
title_fullStr	HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
title_full_unstemmed	HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
title_sort	hpv-16 e2/e6 and pou5f1b as biomarkers to determine cervical high-grade squamous lesions and more
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/5bfb4c49d82d4e2696e69cc742745c8b
work_keys_str_mv	AT chenl hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore AT dongb hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore AT gaoh hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore AT xueh hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore AT pand hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore AT sunp hpv16e2e6andpou5f1basbiomarkerstodeterminecervicalhighgradesquamouslesionsandmore
_version_	1718395760758751232

HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More

Ejemplares similares